Applications of Artificial Intelligence for Organic Chemistry: The DENDRAL Project
By R. K. Lindsay, Bruce G. Buchanan, E. Feigenbaum, J. Lederberg. 1980
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Kai Blin
- M. Mullowney
- Vimla L. Patel
- Philippe Schwaller
- Marwin H. S. Segler
- Nadine Ziemert
- Felicity Allen
- Katherine R. Duncan
Citations in the corpus
- Unsupervised Graph-basedWord Sense Disambiguation Using Measures of Word Semantic Similarity (2007, unknown): “These systems have been successfully applied to tasks such as medical diagnosis [5] and helping chemists identify unknown organic molecules [ 16 ].”
- The Coming of Age of Artificial Intelligence in Medicine (2008, background): “Early AI in medicine (AIM) researchers had discovered the applicability of AI methods to life sciences, most visibly in the Dendral experiments [2] of the late 1960s and early 1970s, which brought together computer scientists (e.”
- Solving the Multiple Instance Problem with Axis-Parallel Rectangles (1997, unknown): “Keywords: Machine learning; Drug design; Structure-activity relationships”
- Multi-Instance Learning : A Survey (2004, background): “Key words: Learning from Examples; Multi-Instance Learning; Supervised Learning”
- Searching molecular structure databases with tandem mass spectra using CSI:FingerID (2015, methodology): “Computational approaches for interpreting and predicting MS/MS data of small molecules date back to the 1960s (9): Due to the unavailability of molecular structure databases at that time, structure libraries were combinatorially generated and then “ searched ” using the experimental MS/MS data.”
- Amplify scientific discovery with artificial intelligence (2014, background): “Also in the 1970s, Joshua Lederberg (another Nobel winner) and colleagues developed the DENDRAL system for analyzing mass spectrometry data in order to hypothesize molecular structures ( 2 ).”
- Competitive fragmentation modeling of ESI-MS/MS spectra for putative metabolite identification (2013, background): “For these cases, one approach to metabolite identification involves first predicting the MS or MS/MS spectrum for each candidate compound from its chemical structure (Heinonen et al. 2008; Wolf et al. 2010; Lindsay et al. 1980; Gasteiger et al. 1992).”
- Artificial Intelligence For Natural Product Drug Discovery (2023, methodology): “Since as early as 1960, AI has been used to complement rule-based approaches in de novo identification of unknown compounds from MS data 41,42 .”